Quadripolar CRT-D On Currently Approved Lead SystemS

NCT ID: NCT02232984

Last Updated: 2019-04-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

749 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate different ways to program around extracardiac stimulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All study patients

All study patients will be implanted with a Boston Scientific (BSC) quadripolar Cardiac Resynchronization Therapy (CRT-D) and a currently approved quadripolar left ventricular lead. At the pre-discharge visit, multiple vectors will be tested in order to assess their respective performance.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is medically indicated for implantation with a Boston Scientific (BSC) DYNAGEN or INOGEN X4 CRT-D (or any future FDA approved BSC X4 CRT-D) and already implanted with/scheduled to receive a commercially available quadripolar left ventricular lead
* Subject is willing and capable of providing informed consent and participating in all testing and study visits associated with this investigation at an approved center and at the intervals defined by this protocol
* Subject is age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria

* Subject has a known or suspected sensitivity to dexamethasone acetate (DXA)
* Subject is enrolled in any other concurrent study, without prior approval from BSC
* Women of childbearing potential who are or might be pregnant at the time of study enrollment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher R Ellis, MD

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University Medical Center, Nashville, TN

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mercy Gilbert Medical Center

Gilbert, Arizona, United States

Site Status

Phoenix Cardiovascular Research Group/ Heart & Vascular Center of Arizona

Phoenix, Arizona, United States

Site Status

St. Joseph's Hospital

Phoenix, Arizona, United States

Site Status

Yuma Regional Medical Center

Yuma, Arizona, United States

Site Status

Cardiology Associates of Northeast Arkansas

Jonesboro, Arkansas, United States

Site Status

Central Arkansas Veterans Healthcare System

Little Rock, Arkansas, United States

Site Status

Comprehensive Cardiovascular Medical Group

Bakersfield, California, United States

Site Status

Cardiac Device Rhythm Specialists, Inc

Los Angeles, California, United States

Site Status

Desert Heart Rhythm

Palm Springs, California, United States

Site Status

Bradenton Cardiology Center

Bradenton, Florida, United States

Site Status

North Florida Regional Medical Center

Gainesville, Florida, United States

Site Status

North Florida VA

Gainesville, Florida, United States

Site Status

Northeast Cardiology Clinic

Jacksonville, Florida, United States

Site Status

Watson Center Clinic for Research

Lakeland, Florida, United States

Site Status

Charlotte Heart

Port Charlotte, Florida, United States

Site Status

Brevard Cardiovascular Res. Associates

Rockledge, Florida, United States

Site Status

Central Florida Regional

Sanford, Florida, United States

Site Status

Sarasota Memorial Hosptial

Sarasota, Florida, United States

Site Status

Northside Hospital

St. Petersburg, Florida, United States

Site Status

Tallahassee Memorial

Tallahassee, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

Atlanta Heart Specialist

Atlanta, Georgia, United States

Site Status

AnMed Health

Augusta, Georgia, United States

Site Status

University Hospital

Augusta, Georgia, United States

Site Status

North Georgia Heart Foundation

Gainesville, Georgia, United States

Site Status

Northeast Georgia Medical Center

Gainesville, Georgia, United States

Site Status

West Suburban Hospital

Oak Park, Illinois, United States

Site Status

Central DuPage Medical Center

Winfield, Illinois, United States

Site Status

Lutheran Hospital

Fort Wayne, Indiana, United States

Site Status

Parkview Hospital

Fort Wayne, Indiana, United States

Site Status

Community Hospital

Munster, Indiana, United States

Site Status

Baptist Health Lexington

Lexington, Kentucky, United States

Site Status

Ark-La-Tex Cardiology, APMC

Shreveport, Louisiana, United States

Site Status

Willis Knighton

Shreveport, Louisiana, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

St. John Hospital and Medical Center

Detroit, Michigan, United States

Site Status

Hurley Hospital

Flint, Michigan, United States

Site Status

Genesys Medical Center

Grand Blanc, Michigan, United States

Site Status

Allegiance Health

Jackson, Michigan, United States

Site Status

Lakeland Medical Center

Saint Joseph, Michigan, United States

Site Status

HealthEast St. Joseph's Hospital

Saint Paul, Minnesota, United States

Site Status

Desert Springs

Las Vegas, Nevada, United States

Site Status

Catholic Medical Center

Manchester, New Hampshire, United States

Site Status

Atlanticare Regional Medical Center

Atlantic City, New Jersey, United States

Site Status

Hackensack University Medical Center

Hackensack, New Jersey, United States

Site Status

Mercy Hospital/ Buffalo Heart Group

Buffalo, New York, United States

Site Status

Genesis Health System

Zanesville, Ohio, United States

Site Status

Bryn Mawr Hospital

Bryn Mawr, Pennsylvania, United States

Site Status

Mercer Bucks Cardiology

Newtown, Pennsylvania, United States

Site Status

Regional Hospital of Scranton

Scranton, Pennsylvania, United States

Site Status

Core CV Research

Jackson, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Houston Arrhythmia Associates

Houston, Texas, United States

Site Status

Houston Cardiovascular Associates

Houston, Texas, United States

Site Status

Heart Institute of East Texas

Lufkin, Texas, United States

Site Status

Woodlands North Houston Heart Ctr

The Woodlands, Texas, United States

Site Status

The University of Vermont Medical Center

Burlington, Vermont, United States

Site Status

Hunter Holmes VA Medical Center

Richmond, Virginia, United States

Site Status

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status

Belin Healthcare

Green Bay, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CROSSX4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Image Supported Lead Placement in CRT
NCT05053568 ACTIVE_NOT_RECRUITING NA
Cardiac Resynchronisation Study
NCT01213537 COMPLETED